FDA NDC Directory · JSON-LD · Markdown

RETEVMO

NDC 0002-5340 · HUMAN PRESCRIPTION DRUG · TABLET, COATED

Generic nameselpercatinib
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA218160
Dosage form / routeTABLET, COATED · ORAL
Active ingredientsSELPERCATINIB (40 mg/1)
Marketing started20240410
Package count1

External sources

Source: openFDA. Public-domain (CC0).